Literature DB >> 2441269

Dual actions of adenosine on rat peritoneal mast cells.

M J Lohse, K Maurer, H P Gensheimer, U Schwabe.   

Abstract

The effects of adenosine and its analogues on cAMP-responses and histamine release of rat peritoneal mast cells were investigated. The adenosine analogue 5'-N-ethylcarboxamidoadenosine (NECA') activates the adenylate cyclase of the mast cell membranes and elevates the cAMP-levels of the intact mast cells. Both effects are antagonized by methylxanthines, suggesting that they are mediated via an A2 adenosine receptor. Adenosine and its analogues enhance the release of histamine from these cells, when the release is stimulated either by the calcium ionophore A 23187 or by concanavalin A. However, this effect is not antagonized by theophylline or 8-phenyltheophylline. In contrast, it is antagonized by the adenosine uptake blockers S-(p-nitrobenzyl)-6-thioinosine (NBTI) and S-(p-nitrobenzyl)-6-thioguanosine (NBTG). It is concluded that adenosine has two different effects on mast cells: it activates adenylate cyclase via an A2 adenosine receptor, and it enhances histamine release via an action at an intracellular site.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441269     DOI: 10.1007/bf00169124

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  The effect of adenosine and its analogues on cyclic AMP changes and histamine secretion from rat peritoneal mast cells stimulated by various ligands.

Authors:  A Leoutsakos; F L Pearce
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

2.  Potentiation of mast cell mediator release by adenosine.

Authors:  D L Marquardt; C W Parker; T J Sullivan
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

3.  Simultaneous inhibitions of inositol phospholipid breakdown, arachidonic acid release, and histamine secretion in mast cells by islet-activating protein, pertussis toxin. A possible involvement of the toxin-specific substrate in the Ca2+-mobilizing receptor-mediated biosignaling system.

Authors:  T Nakamura; M Ui
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  The enzymatic preparation of [alpha-(32)P]nucleoside triphosphates, cyclic [32P] AMP, and cyclic [32P] GMP.

Authors:  T F Walseth; R A Johnson
Journal:  Biochim Biophys Acta       Date:  1979-03-28

5.  Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells.

Authors:  M K Church; P J Hughes; C J Vardey
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

6.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

7.  Adenosine receptor on human basophils: modulation of histamine release.

Authors:  G Marone; S R Findlay; L M Lichtenstein
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

8.  Agonist photoaffinity labeling of A1 adenosine receptors: persistent activation reveals spare receptors.

Authors:  M J Lohse; K N Klotz; U Schwabe
Journal:  Mol Pharmacol       Date:  1986-10       Impact factor: 4.436

9.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

10.  Nitrobenzylthioinosine binding in brain: an interspecies study.

Authors:  A Verma; P J Marangos
Journal:  Life Sci       Date:  1985-01-21       Impact factor: 5.037

View more
  12 in total

1.  Adenosine regulates the Ca2+ sensitivity of mast cell mediator release.

Authors:  M J Lohse; K N Klotz; M J Salzer; U Schwabe
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  A1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and to phospholipase C.

Authors:  S Freund; M Ungerer; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

3.  Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation.

Authors:  X Jin; R K Shepherd; B R Duling; J Linden
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Adenosine enhances antigen-induced bronchoconstriction and histamine release in rat isolated lungs.

Authors:  M J Post; J D te Biesebeek; J Wemer; H H van Rooij; A J Porsius
Journal:  Agents Actions       Date:  1990-04

5.  Phosphatidylcholine-specific phospholipase D-derived 1,2-diacylglycerol does not initiate protein kinase C activation in the RBL 2H3 mast-cell line.

Authors:  P Lin; W J Fung; A M Gilfillan
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

6.  Purine metabolite inosine is an adrenergic neurotrophic substance for cultured chicken sympathetic neurons.

Authors:  A D Zurn; K Q Do
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Synergistic effects of calcium-mobilizing agents and adenosine on histamine release from rat peritoneal mast cells.

Authors:  M J Lohse; K Maurer; K N Klotz; U Schwabe
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

8.  Degranulation of rat omental mast cells by A(1) receptor agonists in vitro.

Authors:  A M Northover; B J Northover
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

9.  Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.

Authors:  Yuesheng Li; Robert A Figler; Glynis Kolling; Tara C Bracken; Jayson Rieger; Ralph W Stevenson; Joel Linden; Richard L Guerrant; Cirle Alcantara Warren
Journal:  BMC Infect Dis       Date:  2012-12-10       Impact factor: 3.090

10.  Mast cell amines and inosineinduced vasoconstriction in the rat hind limb.

Authors:  A M Northover; B J Northover
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.